Filtered By:
Specialty: Health Management
Condition: Hemorrhagic Stroke
This page shows you your search results in order of date.
Order by Relevance | Date
Total 41 results found since Jan 2013.
Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients
ConclusionsThe use of a blood biomarker test to guide pre-hospital thrombolysis is cost-effective compared with standard hospital care in patients with ischemic stroke.
Source: The European Journal of Health Economics - July 27, 2022 Category: Health Management Source Type: research
CUPID research: Finding faster ways to pinpoint the deadliest strokes
Although fewer than one in five strokes is caused by intracerebral hemorrhage (ICH), or bleeding in the brain, this type of stroke is the deadliest. A new study led by Dr. Aarti Sarwal, professor of neurology at Wake Forest University School of Medicine, is examining whether it is possible to identify patients with an ICH stroke before they get to the hospital in order to help these patients get life-saving care without delay.
“For ICH, outcomes tend to be much worse if patients get specialized…
Source: bizjournals.com Health Care News Headlines - June 14, 2022 Category: Health Management Authors: Atrium Health Wake Forest Baptist Source Type: news
The IMPact of UntReated NOn-Valvular Atrial Fibrillation on Short-TErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model
CONCLUSION: Our findings suggest that increased overall OAC use has a positive clinical benefit on the annual number of ischemic stroke events and deaths avoided in the Medicare population, while maintaining a modest increase in the overall BI to the Medicare system.PMID:34415229 | DOI:10.1080/13696998.2021.1970954
Source: Journal of Medical Economics - August 20, 2021 Category: Health Management Authors: Matthew Sussman Manuela Di Fusco Charles Y Tao Jennifer D Guo John A Gillespie Mauricio Ferri Nicholas Adair Matthew S Cato Ilnaz Shirkhorshidian Geoffrey D Barnes Source Type: research
Attributable societal costs of first-incident obesity-related cardiovascular comorbidities in Denmark
Conclusion: The onset of obesity-related cardiovascular comorbidities affected health-care costs and work ability to an extent where sick pay and disability pension were required. Our study demonstrates the need to intensify obesity and cardiovascular disease risk factor management to prevent costly and debilitating obesity-related comorbidities.PMID:33794723 | DOI:10.1080/14737167.2021.1908130
Source: Expert Review of Pharmacoeconomics and Outcomes Research - April 2, 2021 Category: Health Management Authors: Jakob Kjellberg Christian K Tikkanen Source Type: research
Adjunctive Statin Therapy Reduces Mortality After Acute Hemorrhagic Stroke
Source: Risk Management and Healthcare Policy - January 13, 2021 Category: Health Management Tags: Risk Management and Healthcare Policy Source Type: research
Cost-effectiveness analysis of apixaban compared to other direct oral anticoagulants for prevention of stroke in Austrian atrial fibrillation patients.
CONCLUSION: In patients with AF and an increased risk of stroke, prophylaxis with apixaban was highly cost-effective from the perspective of the Austrian health care system.
PMID: 32700584 [PubMed - as supplied by publisher]
Source: Expert Review of Pharmacoeconomics and Outcomes Research - July 24, 2020 Category: Health Management Tags: Expert Rev Pharmacoecon Outcomes Res Source Type: research
Hemichorea – A Rare Sequela of Striatal Infarction
We present a rare case of hemichorea associated with a hemorrhagic stroke in the contralateral striatum.
Source: Journal of the American Medical Directors Association - February 27, 2020 Category: Health Management Authors: Ali Ahmad, Ali Ahmad, Karun Badwal, Shanojan Thiyagalingam, Halina Kusz, Paul Takahashi Source Type: research
Does X(a) mark the spot? An indirect mixed treatment comparison of Xa inhibitors compared to warfarin for patients with Atrial Fibrillation
ConclusionsThe Non-vitamin K antagonist oral anticoagulants constitute a new and promising category in the field of atrial fibrillation, even in the context of uncertainty, which an indirect comparison yields.
Source: Health Policy and Technology - August 10, 2019 Category: Health Management Source Type: research
